Search - tctmd.com

Displaying 541 - 560 of 619

Sort: Relevancy | Date

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

Presentation

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

Presenter: Ziad Hijazi

October 02, 2013

News Daily News

Combination of Remote Pre- and Postconditioning Fails to Help Cardiac Surgery Patients

September 20, 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

September 03, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

September 02, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Higher Persistence in Newly Diagnosed Nonvalvular A-fib Patients Treated with Dabigatran vs. Warfarin

Presentation

Higher Persistence in Newly Diagnosed Nonvalvular A-fib Patients Treated with Dabigatran vs. Warfarin

Presenter: M. Zalesak

August 12, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

August 12, 2013

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Presentation

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Presenter: David Garcia

August 05, 2013

News Daily News

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

August 05, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

August 05, 2013

News Daily News

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

Yael L. Maxwell

August 05, 2013

The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation

Presentation

The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation

Presenter: Stefan H. Hohnloser

August 01, 2013

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Presentation

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Presenter: B. A. Steinberg

July 24, 2013

RE-LY: Dabigatran vs. Warfarin and Hemorrhagic Stroke in Asians and Non-Asians with A-fib

Presentation

RE-LY: Dabigatran vs. Warfarin and Hemorrhagic Stroke in Asians and Non-Asians with A-fib

Presenter: M. Hori

June 21, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Presentation

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Presenter: MW Cullen

June 20, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

June 07, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.